Skip to main content
Intellect

Discovery may lead to lower doses of chemotherapy

  • Many cancer cells resist chemotherapy 
  • BYU chemists found a protein switch that activates resistance
  • The discovery opens the door for medications that will make tumors more sensitive to chemotherapy

No matter what type of chemotherapy you attack a tumor with, many cancer cells resort to the same survival tactic: They start eating themselves.

Scientists at Brigham Young University discovered the two proteins that pair up and switch on this process – known as autophagy.

“This gives us a therapeutic avenue to target autophagy in tumors,” said Josh Andersen, a BYU chemistry professor. “The idea would be to make tumors more chemo-sensitive. You could target these proteins and the mechanism of this switch to block autophagy, which would allow for lower doses of chemotherapy while hopefully improving patient outcomes.”

Lower doses would mean milder side effects. The prospect spurred an international hunt for this switch. For good reason, several other labs started with a protein called ATG9 as their prime suspect and then looked for its accomplice among thousands of other proteins.

But the BYU team, comprised mainly of undergraduate students, stumbled into the race unexpectedly, coming at it from a different direction. They wanted to know why cancer cells made a surplus of protein called 14-3-3 zeta.

Using breast cancer tissue in the lab, they forced tumor cells to undergo autophagy by depriving them of oxygen and glucose. A comparison with a control group let them see that the two proteins hook up only when under attack. That’s because stress makes Atg9 undergo a modification that enables 14-3-3 zeta to bind with it and switch the cancer cells to survival mode.

“This unique approach we used, partially by luck, gave us an advantage,” Andersen said. “I don’t think we would have discovered this through more conventional approaches.”

The study results appear in the journal Molecular and Cellular Biology.

Andersen notes that several medicines already exist that could block autophagy and make chemotherapy more effective. One of them is called chloroquine, an anti-malarial drug invented in 1934. In the event that this and other existing inhibitors don’t cross-over safely or effectively, the study offers a blueprint for development of a drug specific to the task.

Ph.D. candidate Vajira Weerasekara directed the experiments and was lead student author in the study. Undergraduate students David Panek and David Broadbent also made significant contributions to the research and appear as co-authors. When they complete their degrees at BYU, Weeraskara will re-join the faculty at the University of Colombo in Sri Lanka, Panek will go to medical school, and Broadbent will pursue a joint M.D. and Ph.D. program.

Mentored research is a large reason why BYU ranks so highly as a Ph.D. launch pad. According to the National Science Foundation, BYU ranks 5th in the nation for the number of graduates who go on to earn doctorate degrees.

Professor David Thomson in BYU's physiology and developmental biology department collaborated on the research.

Related Articles

data-content-type="article"

Green-thumb dynasty: BYU landscaping wins fifth national championship in six years

March 27, 2024
For the fifth time in six years, BYU students dug, pruned and planted their way to the National Collegiate Landscaping Competition title, the March Madness of college landscaping teams. BYU bested 50 other universities in the four-day event, outscoring the second-place finisher by more than 358 points and breaking the 5000-point total for the first time in the 48-year history of the tournament.
overrideBackgroundColorOrImage= overrideTextColor= overrideTextAlignment= overrideCardHideSection=false overrideCardHideByline=false overrideCardHideDescription=false overridebuttonBgColor= overrideButtonText= overrideTextAlignment=
data-content-type="article"

Forum: How to be a confident pluralist

March 26, 2024
In a democracy where people hold many conflicting views, how do we each honor our own values while making decisions together? Grappling with that question in Tuesday’s forum address, Harvard professor Danielle Allen encouraged her audience to meet this challenge by becoming “confident pluralists.”
overrideBackgroundColorOrImage= overrideTextColor= overrideTextAlignment= overrideCardHideSection=false overrideCardHideByline=false overrideCardHideDescription=false overridebuttonBgColor= overrideButtonText= overrideTextAlignment=
data-content-type="article"

More than money, family and community bonds prep teens for college success

March 21, 2024
Family bonds make the difference in getting teens to college, BYU study says.
overrideBackgroundColorOrImage= overrideTextColor= overrideTextAlignment= overrideCardHideSection=false overrideCardHideByline=false overrideCardHideDescription=false overridebuttonBgColor= overrideButtonText= overrideTextAlignment=
overrideBackgroundColorOrImage= overrideTextColor= overrideTextAlignment= overrideCardHideSection=false overrideCardHideByline=false overrideCardHideDescription=false overridebuttonBgColor= overrideButtonText=